the.com/pid1
PID1 is emerging as a critical target in cancer immunotherapy and disease diagnosis. Researchers are uncovering dual mechanisms where PID1 manipulation can reprogram immune cells to fight tumors and serve as a biomarker for cervical cancer and sepsis.
what's happening
·Targeting PID1 triggers oxysterol production that switches macrophage behavior to enhance antitumor immune responses
·PID1 identified as a biomarker in plasmid reporter systems for cervical cancer detection
·PID1 regulates apoptosis through AKT/Raf-1 pathways in hepatocellular carcinoma cells
·Novel mitochondrial gene signatures involving PID1 improve sepsis diagnosis and predict immune infiltration patterns
drawn from Nature, Phoronix, League City (.gov), Frontiers · updated 17d ago